Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COCs versus vitamin D plus COCs for ovulatory dysfunction bleeding
IRCT20110606006709N22Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ethinyl estradiol, avatrombopag and vitamin d in abnormal uterine bleeding (AUB) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Amount of menstrual bleeding and Days of menstrual bleeding. Started Feb 2021; status: completed.
02
Drugs
ethinyl estradiolavatrombopagvitamin d
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on IRCT20110606006709N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110606006709N22.